Skip to content
Disclosery

Ulys, L.L.C.

Follow

13F filer, CIK 1340098, NEW YORK, NY

Ulys, L.L.C. reported $14,779,000 across 1 holding for the quarter ended 2020-12-31, in a 13F-HR filed 2021-02-11.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001340098-21-000002

Period
2020-12-31
Reported value
$14.8M
Holdings
1
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q4 2020

Share positions as resolved from 13F-HR 0001340098-21-000002, largest first. % of portfolio is the value over $14,779,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LXRXLEXICON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: 4,321,214 shares; 2019Q3: 4,321,214 shares; 2019Q4: 4,321,214 shares; 2020Q1: 4,321,214 shares; 2020Q2: 4,321,214 shares; 2020Q3: 4,321,214 shares; 2020Q4: 4,321,214 shares 4,321,214$14.8M100%0Timeline

How Q4 2020 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001340098-21-000002 base2021-02-11acceptance time not in the bulk data set